Nephropathy - IgA; Berger disease
IgA nephropathy is a kidney disorder in which antibodies (called IgA) build up in kidney tissue. Nephropathy is damage, disease, or other problems with the kidney.
IgA nephropathy is also called Berger disease.
IgA is a protein, called an antibody, that helps the body fight infections. IgA nephropathy occurs when too much of this protein is deposited in the kidneys. IgA builds up inside the small blood vessels of the kidney. Structures in the kidney called glomeruli become inflamed and damaged.
Risk factors include:
IgA nephropathy can occur in people of all ages, but it most often affects males in their teens to late 30s.
There may be no symptoms for many years.
When there are symptoms, they may include:
IgA nephropathy is most often discovered when a person with no other symptoms of kidney problems has one or more episodes of dark or bloody urine.
There are no specific changes seen during a physical examination. Sometimes, the blood pressure may be high or there may be swelling of the body.
The goal of treatment is to relieve symptoms and prevent or delay chronic renal failure.
The treatment may include:
Salt and fluids may be restricted to control swelling. A low-to-moderate protein diet may be recommended in some cases.
Eventually, many people must be treated for chronic kidney disease and may need dialysis.
IgA nephropathy gets worse slowly. In many cases, it does not get worse at all. Your condition is more likely to get worse if you have:
Contact your health care provider if you have bloody urine or if you are producing less urine than usual.
Feehally J, Floege J. Immunoglobulin A nephropathy and IgA vasculitis (Henoch-Schönlein purpura). In: Feehally J, Floege J, Tonelli M, Johnson RJ, eds. Comprehensive Clinical Nephrology. 6th ed. Philadelphia, PA: Elsevier; 2019:chap 23.
Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.BACK TO TOP
Review Date: 7/27/2021
Reviewed By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Health Content Provider
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2023 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.